The Emerging Role of EVA1A in Different Types of Cancers

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Eva-1 homolog A (EVA1A), also known as transmembrane protein 166 (TMEM166), is an endoplasmic reticulum-associated protein.
• EVA1A plays a role in regulating autophagy and apoptosis, processes implicated in various diseases.
• The precise role and mechanisms of EVA1A in cancer pathogenesis remain incompletely understood.

Purpose of the Study:

• To review and synthesize current research on the function of EVA1A in diverse cancer types.
• To analyze the molecular mechanisms underlying EVA1A's involvement in cancer progression.
• To provide a foundation for future investigations into EVA1A as a potential cancer therapeutic target.

Main Methods:

• Literature review of studies investigating EVA1A in cancer.
• Analysis of experimental data linking EVA1A to autophagy and apoptosis pathways.
• Comparative analysis of EVA1A expression and function across different cancer models.

Main Results:

• EVA1A is implicated in the development and progression of multiple cancers, including breast, thyroid, lung, liver, brain, and pancreatic cancers.
• EVA1A influences cancer cell fate through modulation of autophagy and apoptosis.
• Specific mechanisms vary depending on the cancer type, highlighting context-dependent functions.

Conclusions:

• EVA1A is a significant regulator in various cancers, impacting cell death pathways.
• Further research into EVA1A's mechanisms is warranted to explore its therapeutic potential in oncology.
• Understanding EVA1A's role can inform the development of novel cancer treatment strategies.